Literature DB >> 6849734

Effect of sodium acetyl salicylate on cholesterol saturation of fasting gall bladder bile, with and without chenic acid.

R M Kupfer, T C Northfield.   

Abstract

The aims of this study were (a) to determine whether sodium acetyl salicylate by itself or in combination with chenodeoxycholic (chenic) acid would decrease the cholesterol saturation index (SI) of fasting gall bladder bile in man; and (b) to confirm prospectively that 8 mg kg-1 day-1 chenic acid given at bedtime together with a low cholesterol diet reduces gall bladder bile SI to a level where consistent gallstone dissolution would be expected. Seven patients were studied on each of the following regimens given in random order for 1 month each: bedtime chenic acid alone 8 mg kg-1 day-1; sodium acetyl salicylate alone 600 mg four times daily; bedtime chenic acid together with sodium acetyl salicylate; no treatment. Gall bladder samples were taken by nasoduodenal intubation at the end of each regimen and SI determined. SI (mean +/- s.e. mean) on low cholesterol diet with no drug treatment was 1.14 +/- 0.06. On bedtime chenic acid 8 mg kg-1 day-1 plus low cholesterol diet it fell to 0.83 +/- 0.03 (P less than 0.05). Sodium acetyl salicylate did not alter gall bladder bile SI. 95% confidence limits for the effect of sodium acetyl salicylate on SI were +0.03 and -0.05. We conclude that (a) sodium acetyl salicylate does not lower SI of gall bladder bile in man; (b) an adequate fall in SI for gallstone dissolution can be achieved with a reduced dose (8 mg kg-1 day-1) of chenic acid given at bedtime with a low cholesterol diet.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849734      PMCID: PMC1427840          DOI: 10.1111/j.1365-2125.1983.tb01474.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Enzymatic determination of cholesterol in bile.

Authors:  A Roda; D Festi; C Sama; G Mazzella; R Alini; E Roda; L Barbara
Journal:  Clin Chim Acta       Date:  1975-11-03       Impact factor: 3.786

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  Gallstone dissolution in man using chenodeoxycholic acid.

Authors:  G D Bell; B Whitney; R H Dowling
Journal:  Lancet       Date:  1972-12-09       Impact factor: 79.321

4.  The solubility of cholesterol in aqueous solutions of bile salts and lecithin.

Authors:  F G Hegardt; H Dam
Journal:  Z Ernahrungswiss       Date:  1971-04

5.  Dissolution of cholesterol gallstones by chenodeoxycholic acid.

Authors:  R G Danzinger; A F Hofmann; L J Schoenfield; J L Thistle
Journal:  N Engl J Med       Date:  1972-01-06       Impact factor: 91.245

6.  Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.

Authors:  J H Iser; H Dowling; H Y Mok; G D Bell
Journal:  N Engl J Med       Date:  1975-08-21       Impact factor: 91.245

7.  Effect of lysine acetylsalicylate on biliary lipid secretion in dogs.

Authors:  S Erlinger; D Bienfait; R Poupon; M Dumont; M Duval
Journal:  Clin Sci Mol Med       Date:  1975-09

8.  Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man.

Authors:  R T Holzbach; M Marsh; M Olszewski; K Holan
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

9.  The physicochemical basis of cholesterol gallstone formation in man.

Authors:  W H Admirand; D M Small
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

10.  Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.

Authors:  D P Maudgal; R M Kupfer; T C Northfield
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

View more
  1 in total

1.  Oral acetylsalicylic acid induces biliary cholesterol secretion in the rat.

Authors:  W F Prigge; R L Gebhard
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.